- Fool.co.uk•14 hours ago
Royston Wild looks at three FTSE 100 (INDEXFTSE: UKX) stunners you shouldn’t wait to buy.
Value investing is easily one of the most popular ways to find great stocks in any market environment.
- Reuters - UK Focus•2 days ago
LONDON/DAVOS, Switzerland, Jan 19 (Reuters) - G laxoSmithKline's global head of pharmaceuticals, Abbas Hussain, is to leave Britain's biggest drugmaker after being passed over for the top job and will be replaced by Luke Miels from AstraZeneca. Hussain, the brother of former England cricket captain Nasser Hussain, had been a contender to take over from Chief (Taiwan OTC: 3345.TWO - news) Executive Andrew Witty, who steps down at the end of March, but the job went to GSK's consumer health boss Emma Walmsley.
GS7.F: Summary for GLAXOSMITHKLINE LS-,25 - Yahoo Finance
GlaxoSmithKline plc (GS7.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
|Bid||18.08 x 110000|
|Ask||18.35 x 110000|
|Day's range||18.00 - 18.24|
|52-week range||16.92 - 20.57|
|PE ratio (TTM)||235.19|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|